Phase 3 Clinical Trial of Possible COVID-19 Vaccine Begins
Multi-site trial to test candidate developed by Moderna and NIH
Vaccines
Study: We Are Mutating SARS-CoV-2, but It Is Evolving Back
The findings from researchers at the Universities of Bath and Edinburgh could help in the design of vaccines against the virus
COVID-19: RNA Vaccine Has Robust Response in Nonhuman Primates
A single dose induced antibodies in both young and old animal models. The vaccine's design has advantages of safety, cost, scalability, and storage
Bioreactor Designs Respond to Evolving Needs in Vaccine Manufacturing
Faced with limitations of egg-based vaccine production, researchers have turned to other approaches
Separation and Characterization of Viruses and Antibodies
Learn how asymmetrical flow field-flow fractionation (AF4) techniques can help virus, vaccine, and antibody researchers
Infectious Disease eBook
Breakthroughs in developing vaccines, protective immune monitoring, and measuring toxicity with functional proteomics
New Models of COVID-19 Spike Protein Could Be Key to Vaccine
The protein structure facilitates viral entry into host cells making it a key target for vaccine and antiviral drug development, according to the researchers
Targeting T Cells in Lungs Could Mean Immunity against Respiratory Viruses
Salk and Yale study of influenza could inform vaccines for COVID-19 and other lung diseases
Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery
How the ZetaView Nanoparticle Tracking Analyzer is helping researchers develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria
How the Novel Coronavirus Jumped from Animals to Humans
The virus's ability to change makes it likely that new human coronaviruses will arise